• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button Iconimmunotherapy

immunotherapy

A woman in an Allcyte lab coat looking at images of cancer cells on a screen.
TechBritish A.I. drug discovery startup Exscientia buys Austrian cancer cell screening company
By Jeremy KahnJune 15, 2021
Photo of CytoSeek CEO Carolyn Porter
TechNew venture fund backs CytoSeek, a startup looking to give “superpowers” to cancer-fighting T-cells
By Jeremy KahnMarch 16, 2021
A man with his shirt off and wearing a mask receives a COVID-19 vaccination from a health worker wearing PPE.
HealthAs mutant COVID variants multiply, the hunt is on for a ‘universal’ kill-all vaccine
By Jeremy KahnFebruary 19, 2021
INV.03.20.Immunotherapy-Drugs
Magazine‘Miracle’ cancer treatments could be a blessing for investors too
By Ryan DerousseauFebruary 13, 2020
USA - Technology - Paul Allen Promotes New Memoir
HealthMicrosoft Co-Founder Paul Allen Says His Cancer Has Returned, Expresses Optimism
By Glenn FleishmanOctober 1, 2018
Immelt Stakes GE's Growth On Higher R&D As NBC, Finance Shrink
HealthThe Secret to Cancer Treatment May Be In Our Guts
By Clifton LeafNovember 3, 2017
A sign is seen at an AstraZeneca site in Macclesfield
HealthHere’s Why Shares in This Former Pfizer Target Are Tanking
By Fortune Editors and ReutersJuly 27, 2017
Fortune Brainstorm Health 2016
HealthSean Parker: This Is How Tech Billionaires Do Philanthropy
By Erika FryNovember 2, 2016
545861099
HealthFirst CRISPR Clinical Trial in Humans Is Approved by Federal Regulators
By STAT NewsJune 22, 2016
Napster co-founder, Sean Parker, General
HealthSean Parker Is Funding the First Human Trials of a Revolutionary Cancer Treatment
By Laura LorenzettiJune 21, 2016
Cancer Consulting Elderly Person
HealthThis Key Merck Cancer Drug Just Got a Huge Boost
By Sy MukherjeeJune 16, 2016
Johns Hopkins Hospital Continues Cancer Research And Treatment
HealthThese Are the Most Promising Experimental Cancer Drugs
By Sy MukherjeeJune 9, 2016
Kim Le, a research associate for FivePrime Therapeutics, wor
HealthThis Obscure Biotech Company May Have a Game-Changing Cancer Med On Its Hands
By Sy MukherjeeJune 6, 2016
Johns Hopkins Hospital Continues Cancer Research And Treatment
HealthHere’s Why Worldwide Cancer Drug Spending Spiked Last Year
By Sy MukherjeeJune 2, 2016
Johns Hopkins Hospital Continues Cancer Research And Treatment
HealthMichael Bloomberg, Others Kick in $125 Million for New Cancer Center
By Laura LorenzettiMarch 29, 2016
1
  • 1
  • 2
2
Most Popular
Success
Japanese companies are paying older workers to sit by a window and do nothing—while Western CEOs demand super-AI productivity just to keep your jobAn image of a popular article
By Orianna Rosa RoyleFebruary 27, 2026
Middle East
Iran is now on 'death ground' amid existential threat from U.S. attacks and could 'go big' in retaliation, former NATO commander warnsAn image of a popular article
By Jason MaFebruary 28, 2026
AI
The week the AI scare turned real and America realized maybe it isn't ready for what's comingAn image of a popular article
By Nick LichtenbergFebruary 28, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
Fortune Secondary Logo
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.